Rating History for ZIOPHARM Oncology (ZIOP) by Raymond James

More Stocks Rated by Raymond James | Latest Ratings for ZIOP
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/9/2021 David Novak Maintain Market Perform
(N/A)		 2.00
(3.00)		  
 		   Details